• English


Medical School

  • New York University School of Medicine , 1990 , New York , NY


  • Hospital of the University of Pennsylvania , 1994 , Philadelphia , PA


  • Hospital of the University of Pennsylvania , 1996 , Philadelphia , PA


  • American Board of Pathology, Blood Banking/Transfusion Medicine


Publications powered by Harvard Catalyst Profiles

  1. Gansner JM, Rahmani M, Jonsson AH, Fortin BM, Brimah I, Ellis M, Smeland-Wagman R, Li ZJ, Schenkel JM, Brenner MB, Yefidoff-Freedman R, Sloan SR, Berliner N, Issa NC, Baden LR, Longo DL, Wesemann DR, Neuberg D, Rao DA, Kaufman RM. Plateletpheresis-associated lymphopenia in frequent platelet donors. Blood. 2019 02 07; 133(6):605-614. View abstract
  2. Yazer MH, Waters JH, Spinella PC. Use of Uncrossmatched Erythrocytes in Emergency Bleeding Situations. Anesthesiology. 2018 03; 128(3):650-656. View abstract
  3. Yazer MH, Seheult J, Kleinman S, Sloan SR, Spinella PC. Who's afraid of incompatible plasma? A balanced approach to the safe transfusion of blood products containing ABO-incompatible plasma. Transfusion. 2018 02; 58(2):532-538. View abstract
  4. Sloan SR. The Potential and Pitfalls of a Dye-Assisted Paper-Based Assay for Blood Grouping. Clin Chem. 2018 03; 64(3):429-430. View abstract
  5. Delaney M, Stark PC, Suh M, Triulzi DJ, Hess JR, Steiner ME, Stowell CP, Sloan SR. Massive Transfusion in Cardiac Surgery: The Impact of Blood Component Ratios on Clinical Outcomes and Survival. Anesth Analg. 2017 06; 124(6):1777-1782. View abstract
  6. Sloan SR. The importance of antibody screens after transfusions. Transfusion. 2016 11; 56(11):2653-2654. View abstract
  7. Sloan SR, Parker RI. Current Status of Platelet Transfusion in Pediatric Patients. Transfus Med Rev. 2016 10; 30(4):230-4. View abstract
  8. Dunbar NM, Raval JS, Johnson A, Abikoff CM, Adamski J, Cooling LL, Grossman B, Kim HC, Marques MB, Morgan S, Schmidt AE, Sloan SR, Su LL, Szczepiorkowski ZM, West FB, Wong E, Schneiderman J. Extracorporeal photopheresis practice patterns: An international survey by the ASFA ECP subcommittee. J Clin Apher. 2017 Aug; 32(4):215-223. View abstract
  9. Price TH, Boeckh M, Harrison RW, McCullough J, Ness PM, Strauss RG, Nichols WG, Hamza TH, Cushing MM, King KE, Young JA, Williams E, McFarland J, Holter Chakrabarty J, Sloan SR, Friedman D, Parekh S, Sachais BS, Kiss JE, Assmann SF. Efficacy of transfusion with granulocytes from G-CSF/dexamethasone-treated donors in neutropenic patients with infection. Blood. 2015 Oct 29; 126(18):2153-61. View abstract
  10. Steiner ME, Ness PM, Assmann SF, Triulzi DJ, Sloan SR, Delaney M, Granger S, Bennett-Guerrero E, Blajchman MA, Scavo V, Carson JL, Levy JH, Whitman G, D'Andrea P, Pulkrabek S, Ortel TL, Bornikova L, Raife T, Puca KE, Kaufman RM, Nuttall GA, Young PP, Youssef S, Engelman R, Greilich PE, Miles R, Josephson CD, Bracey A, Cooke R, McCullough J, Hunsaker R, Uhl L, McFarland JG, Park Y, Cushing MM, Klodell CT, Karanam R, Roberts PR, Dyke C, Hod EA, Stowell CP. Effects of red-cell storage duration on patients undergoing cardiac surgery. N Engl J Med. 2015 Apr 09; 372(15):1419-29. View abstract
  11. Sloan SR, Andrzejewski C, Aqui NA, Kiss JE, Krause PJ, Park YA. Role of therapeutic apheresis in infectious and inflammatory diseases: Current knowledge and unanswered questions. J Clin Apher. 2015 Oct; 30(5):259-64. View abstract
  12. Ratcliffe N, Dunbar NM, Adamski J, Couriel D, Edelson R, Kitko CL, Levine JE, Morgan S, Schneiderman J, Sloan S, Wu Y, Szczepiorkowski ZM, Cooling L. National Institutes of Health State of the Science Symposium in Therapeutic Apheresis: scientific opportunities in extracorporeal photopheresis. Transfus Med Rev. 2015 Jan; 29(1):62-70. View abstract
  13. Josephson CD, Mondoro TH, Ambruso DR, Sanchez R, Sloan SR, Luban NL, Widness JA. One size will never fit all: the future of research in pediatric transfusion medicine. Pediatr Res. 2014 Nov; 76(5):425-31. View abstract
  14. Callum JL, Waters JH, Shaz BH, Sloan SR, Murphy MF. The AABB recommendations for the Choosing Wisely campaign of the American Board of Internal Medicine. Transfusion. 2014 Sep; 54(9):2344-52. View abstract
  15. Liew WK, Powell CA, Sloan SR, Shamberger RC, Weldon CB, Darras BT, Kang PB. Comparison of plasmapheresis and intravenous immunoglobulin as maintenance therapies for juvenile myasthenia gravis. JAMA Neurol. 2014 May; 71(5):575-80. View abstract
  16. Valentine SL, Lightdale JR, Tran CM, Jiang H, Sloan SR, Kleinman ME, Randolph AG. Assessment of hemoglobin threshold for packed RBC transfusion in a medical-surgical PICU. Pediatr Crit Care Med. 2014 Feb; 15(2):e89-94. View abstract
  17. Kim YA, Sloan SR. Pediatric therapeutic apheresis: rationale and indications for plasmapheresis, cytapheresis, extracorporeal photopheresis, and LDL apheresis. Pediatr Clin North Am. 2013 Dec; 60(6):1569-80. View abstract
  18. Delaney M, Capocelli KE, Eder AF, Schneiderman J, Schwartz J, Sloan SR, Wong EC, Kim HC. An international survey of pediatric apheresis practice. J Clin Apher. 2014 Apr; 29(2):120-6. View abstract
  19. Samnaliev M, Tran CM, Sloan SR, Gasior I, Lightdale JR, Brustowicz RM. Economic evaluation of cell salvage in pediatric surgery. Paediatr Anaesth. 2013 Nov; 23(11):1027-34. View abstract
  20. Sloan SR, Steiner ME, Stowell CP, Assmann SF, Delaney M, Triulzi D. Current randomized clinical trials of red cell storage duration and patient outcomes. Crit Care Med. 2012 Oct; 40(10):2927; author reply 2927-8. View abstract
  21. Josephson CD, Granger S, Assmann SF, Castillejo MI, Strauss RG, Slichter SJ, Steiner ME, Journeycake JM, Thornburg CD, Bussel J, Grabowski EF, Neufeld EJ, Savage W, Sloan SR. Bleeding risks are higher in children versus adults given prophylactic platelet transfusions for treatment-induced hypoproliferative thrombocytopenia. Blood. 2012 Jul 26; 120(4):748-60. View abstract
  22. Ambruso DR, Sanchez R, Sloan SR, Josephson CD. How do we teach pediatric topics in transfusion medicine: curriculum development, learners, and instructional strategies. Transfusion. 2013 Feb; 53(2):250-6. View abstract
  23. Sloan SR. Tolerant heaven or mHEL trouble. Blood. 2012 Feb 09; 119(6):1330-1. View abstract
  24. Sloan SR. Transfusions for patients with sickle cell disease at Children's Hospital Boston. Immunohematology. 2012; 28(1):17-9. View abstract
  25. Lightdale JR, Randolph AG, Tran CM, Jiang H, Colon A, Houlahan K, Billet A, Sloan S, Lehmann LE. Impact of a conservative red blood cell transfusion strategy in children undergoing hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2012 May; 18(5):813-7. View abstract
  26. Campbell Lee S, Shaz B, Arena R, Sloan S, Fung M, Ramsey G. Red blood cell products: consideration of the discrepant temperature ranges permitted for storage versus transport. Transfusion. 2012 Jan; 52(1):195-200. View abstract
  27. Sloan SR. Neonatal transfusion review. Paediatr Anaesth. 2011 Jan; 21(1):25-30. View abstract
  28. Spinella PC, Dressler A, Tucci M, Carroll CL, Rosen RS, Hume H, Sloan SR, Lacroix J. Survey of transfusion policies at US and Canadian children's hospitals in 2008 and 2009. Transfusion. 2010 Nov; 50(11):2328-35. View abstract
  29. Shaikh S, Sloan SR. Clearance of maternal isohemagglutinins from infant circulation (CME). Transfusion. 2011 May; 51(5):938-42. View abstract
  30. Steiner ME, Assmann SF, Levy JH, Marshall J, Pulkrabek S, Sloan SR, Triulzi D, Stowell CP. Addressing the question of the effect of RBC storage on clinical outcomes: the Red Cell Storage Duration Study (RECESS) (Section 7). Transfus Apher Sci. 2010 Aug; 43(1):107-16. View abstract
  31. Slichter SJ, Kaufman RM, Assmann SF, McCullough J, Triulzi DJ, Strauss RG, Gernsheimer TB, Ness PM, Brecher ME, Josephson CD, Konkle BA, Woodson RD, Ortel TL, Hillyer CD, Skerrett DL, McCrae KR, Sloan SR, Uhl L, George JN, Aquino VM, Manno CS, McFarland JG, Hess JR, Leissinger C, Granger S. Dose of prophylactic platelet transfusions and prevention of hemorrhage. N Engl J Med. 2010 Feb 18; 362(7):600-13. View abstract
  32. Sloan, Steven R. Hemolytic Anemia. Essential Evidence, M. Ebell editor. 2010. View abstract
  33. Sanchez R, Sloan SR, Josephson CD, Ambruso DR, Hillyer CD, O'Sullivan P. Consensus recommendations of pediatric transfusion medicine objectives for clinical pathology residency training programs. Transfusion. 2010 May; 50(5):1071-8. View abstract
  34. Gordon DJ, Sloan SR, de Jong JL. A pediatric case series of acute hemolysis after administration of intravenous immunoglobulin. Am J Hematol. 2009 Nov; 84(11):771-2. View abstract
  35. Hillyer CD, Mondoro TH, Josephson CD, Sanchez R, Sloan SR, Ambruso DR. Pediatric transfusion medicine: development of a critical mass. Transfusion. 2009 Mar; 49(3):596-601. View abstract
  36. Westhoff CM, Sloan SR. Molecular genotyping in transfusion medicine. Clin Chem. 2008 Dec; 54(12):1948-50. View abstract
  37. Higgins J, Sloan S. A stochastic model of RBC alloimmunization suggests a distinct population of "Responders". Transfusion. 2008; 48(2):9A. View abstract
  38. Higgins J, Sloan S. Does one antibody lead to another? Patterns in RBC alloantibody formation. Transfusion. 2008; 48(2):176A. View abstract
  39. Higgins JM, Sloan SR. Stochastic modeling of human RBC alloimmunization: evidence for a distinct population of immunologic responders. Blood. 2008 Sep 15; 112(6):2546-53. View abstract
  40. Sloan SR. Technical issues in neonatal transfusions. Immunohematology. 2008; 24(1):4-9. View abstract
  41. Sloan, Steven R. Blood Products Used in the Newborn. Manual of Neonatal Care, Cloherty JP, Eichenwald EC, and Stark AR, editors. 2008; 463-469. View abstract
  42. Higgins JM, Sloan SR. Relative immunogenic strengths of RBC antigens in a pediatric poplulation. Transfusion. 2007; 47(3):163A-164A. View abstract
  43. Kaufman, RM Sloan, SR. Transfusion in bone marrow and solid organ transplant recipients. Blood Banking and Transfusion Medicine. 2006. View abstract
  44. Roseff SD, editor. Eder A, Hume H, Pisciotto P, Sloan S, Strauss R, contributing editors. Pediatric Transfusion; A Physician's Handbook. 2006; 208. View abstract
  45. Mauriello T, Wills R, Beaton M, Sloan R. LDL apheresis treatment in a pregnant woman wiht homozygous familial hypercholesterolemia. Transfusion. 2005; 45(3):38A. View abstract
  46. Cavanaugh PA, Doherty J, Beaton M, Sloan S. Transfusion reactions in a pediatric hospital. Transfusion. 2005; 45(3):110A. View abstract
  47. Haspel RL, Walsh L, Sloan SR. Risk of Rh(D) alloimmunization after transfusion of platelets from D+ donors to D- recipients - Reply. Transfusion. 2005; 45(3):453-454. View abstract
  48. Conlan MG, Stassinopoulos A, Garratty G, Wages D, Corash L, Wood L, Sloan SR, Labotka RJ. Antibody Formation to S-303-Treated RBCS in the Setting of Chronic RBC Transfusion. Blood. 2004; 104(11):382. View abstract
  49. Willis R, Beaton M, Sloan S, Miller D, Dummer CW, Rogers M, Cox D. A Multi-Site Method Comparison Trial Using the Critscan Hematocrit Measuring Device. Transfusion. 2004; 44(9S):10A. View abstract
  50. Framil RC, Doherty J, Beaton M, Sloan S. Inventory Management Challenges in a Pediatric Hospital with a 100% Irradiation Policy. Transfusion. 2004; 44(9S):107A. View abstract
  51. Boyd J, Sloan S, Meffert J. Elephantiasis nostrum verrucosa of the abdomen: clinical results with tazarotene. J Drugs Dermatol. 2004 Jul-Aug; 3(4):446-8. View abstract
  52. Haspel RL, Walsh L, Sloan SR. Platelet transfusion in an infant leading to formation of anti-D: implications for immunoprophylaxis. Transfusion. 2004 May; 44(5):747-9. View abstract
  53. Kao GS, Sloan SR. Peripheral Blood Stem Cells. Hillyer CD, Strauss RG, Luban NLC, editors. Handbook of Pediatric Transfusion Medicine. 2004; 283-293. View abstract
  54. Kao G, Sloan SR. Bone Marrow-Derived Stem Cells. Hillyer CD, Strauss RG, Luban NLC, editors. Handbook of Pediatric Transfusion Medicine. 2004; 271-281. View abstract
  55. Sloan SR. Blood Products Used in the Newborn. Cloherty JP, Eichenwald EC, Stark AR, editors. Manual of Neonatal Care. 2004; 487-492. View abstract
  56. Lu J, Honczarenko M, Sloan SR. Independent expression of the two paralogous CCL4 genes in monocytes and B lymphocytes. Immunogenetics. 2004 Jan; 55(10):706-11. View abstract
  57. Cunningham, M.J., Sloan, S.R. Minimizing Autologous Peripheral Leukapheresis Procedures for Pediatric Neuroblastoma Patients. Blood. 2003; 102(11):3027. View abstract
  58. Silberstein LE, Sloan SR, Doherty J, Beaton M, Kenny F, Woodbury C, Hall JA. Pan-genera Detection of Bacterial Contamination in Platelet Units. Transfusion. 2003; 43(9S):48A. View abstract
  59. Sloan SR, Silberstein LE. Transfusion Medicine. Furie B, Cassileth PA, Atkins MB, Mayer RJ, editors. Clinical Hematology and Oncology: Presentation, Diagnosis, and Treatment. 2003; 431-440. View abstract
  60. Sloan SR, Benjamin RJ, Friedman DE, Webb IJ, Silberstein L. Transfusion Medicine. Nathan DG, Orkin SH, Ginsburg D, Look AT, editors. Nathan and Oski's Hematology of Infancy and Childhood. 2003; 1709-1756. View abstract
  61. Roseff SD, editor. Chambers L, Eder A, Pisciotto P, Sloan S, Strauss R, contributing editors. Pediatric Transfusion: A Physician's Handbook. 2003. View abstract
  62. Doherty J, Parr M, Larrivee A, Beaton M, Sloan SR. Testing Non-group-O Neonates for Passively Acquired ABO Antibodies: Is 4 Months too Old?. Transfusion. 2002; 42(9S):96S. View abstract
  63. Lu J, Sloan SR. The basic helix-loop-helix domain of the E47 transcription factor requires other protein regions for full DNA binding activity. Biochem Biophys Res Commun. 2002 Feb 08; 290(5):1521-8. View abstract
  64. Lu J, Sloan SR. Phage-displayed antibodies to detect cell markers. Methods Mol Biol. 2002; 185:381-92. View abstract
  65. Willis, R.L., Beaton, M.A.,Sloan, S.R. Collaboration among all Donor Center Staff Improves Recruitment and Collections. Transfusion. 2001; 41(9S):AP25. View abstract
  66. Zubair, A.C., Beaton, M.A., Sloan, S.R. RBC T Activation and Severe Hemolysis in a Three-Month Old Infant. Transfusion. 2001; 41(9S):SP192. View abstract
  67. Sloan SR, Jefferies L. Evaluation and Management of Transfusion Reactions. Lanken PN, Hanson CW, Manaker S, editors. The Intensive Care Unit Manual. 2001; 531-539. View abstract
  68. Sloan SR. Peripheral-Blood-Derived Hematopoietic Progenitor Cells. Hillyer CD, Hillyer KL, Strobl FJ, Jefferies LC, Silberstein LE, editors. Handbook of Transfusion Medicine. 2001; 161-170. View abstract
  69. Sloan SR. Book Review: Phage Display: A Laboratory Manual. The Quarterly Review of Biology. 2001; 76:487-488. View abstract
  70. Lu J, Sloan SR. Phage Displayed Antibodies to Detect Cell Markers. Methods in Molecular Biology: Embryonic Stem Cells Methods and Protocols. 2001; 185:381-392. View abstract
  71. Sloan SR. Bone-Marrow Derived Hematopoetic Progenitor Cells. Hillyer CD, Hillyer KL, Strobl FJ, Jefferies LC, Silberstein LE, editors. Handbook of Transfusion Medicine. 2001; 149-159. View abstract
  72. Cinat ME, Wallace WC, Nastanski F, West J, Sloan S, Ocariz J, Wilson SE. Improved survival following massive transfusion in patients who have undergone trauma. Arch Surg. 1999 Sep; 134(9):964-8; discussion 968-70. View abstract
  73. Lu J, Sloan SR. An alternating selection strategy for cloning phage display antibodies. J Immunol Methods. 1999 Aug 31; 228(1-2):109-19. View abstract
  74. Wallace WC, Burchell, Ocariz J, Sloan S, West J, Cinat ME. Improved survival in trauma patients receiving massive transfusion. Critical Care Medicine. 1999; 27(1):A176. View abstract
  75. Sloan SR. Diseases associated with the major histocompatibility complex. West J Med. 1997 Jul; 167(1):36-7. View abstract
  76. Sloan SR, Silberstein L. Transfusion in the face of Autoantibodies. Reid ME, Nance SJ, editors. Red Blood Cell Transfusions: A Practical Guide. 1997. View abstract
  77. Sloan SR, Shen CP, McCarrick-Walmsley R, Kadesch T. Phosphorylation of E47 as a potential determinant of B-cell-specific activity. Mol Cell Biol. 1996 Dec; 16(12):6900-8. View abstract
  78. Sloan, S.R., Shen, C., Kadesch, T. Hypophosphorylation of the Human E2A protein results in a B cell specific transcription factor. Transfusion. 1995; 35(10S):39S. View abstract
  79. Kamoun M, Zerva L, Sloan S, Zmijewski C, Monos D, Trinchieri G. Induction of HLA class II molecules on human T cells: relationship to immunoregulation and the pathogenesis of AIDS. DNA Cell Biol. 1992 Apr; 11(3):265-8. View abstract
  80. Sloan SR, Pellicer A. Activation of the ras oncogene in gamma radiation and neutron radiation induced thymic lymphomas. Prog Clin Biol Res. 1992; 374:1-18. View abstract
  81. Sloan SR, Pellicer A. Activation of the ras oncogene in gamma radiation and neutron radiation induced thymic lymphomas. Relevance of Animal Studies to Evaluation of Human Cancer Risk. 1992; 1-18. View abstract
  82. Sloan SR, Pellicer A. Ras oncogene activation in gamma- and neutron- radiation induced murine thymic lymphomas. Dewey WC, Edington M, Fry RJM, Hall EJ, Whitmore GF, editors. 9th International Congress of Radiation Research. 1992; 353-357. View abstract
  83. Corominas M, Sloan SR, Leon J, Kamino H, Newcomb EW, Pellicer A. ras activation in human tumors and in animal model systems. Environ Health Perspect. 1991 Jun; 93:19-25. View abstract
  84. Sloan SR, Pellicer A. Staging of T-cell receptor beta chain gene rearrangements and ras oncogene mutations in the development of murine thymic lymphomas. Cancer Res. 1991 Mar 15; 51(6):1627-31. View abstract
  85. Sloan SR, Pellicer A. Oncogene activation in radiation induced tumors. 1991 Annual Meeting of the National Council of Radiation Protection and Measurements. 1991. View abstract
  86. Sloan SR, Newcomb EW, Pellicer A. Neutron radiation can activate K-ras via a point mutation in codon 146 and induces a different spectrum of ras mutations than does gamma radiation. Mol Cell Biol. 1990 Jan; 10(1):405-8. View abstract
  87. Newcomb EW, Diamond LE, Sloan SR, Corominas M, Guerrerro I, Pellicer A. Radiation and chemical activation of ras oncogenes in different mouse strains. Environ Health Perspect. 1989 May; 81:33-7. View abstract
  88. Diamond LE, Sloan SR, Pellicer A, Hayday AC. T-cell receptor gene rearrangement in primary tumors: effect of genetic background and inducing agent. Immunogenetics. 1988; 28(2):71-80. View abstract
  89. Weaver JC, Mintzer RA, Ling H, Sloan SR. Conduction Onset Criteria for Transient Aqueous Pores and Reversible Electrical Breakdown in Bilayer-Membranes. Bioelectrochemistry and Bioenergetics. 1986; 15(2):229-241. View abstract
  90. Weaver JC, Powell KT, Mintzer RA, Ling H, Sloan SR. The Electrical Capacitance of Bilayer-Membranes the Contribution of Transient Aqueous Pores. Bioelectrochemistry and Bioenergetics. 1984; 12(3-4):393-404. View abstract
  91. Weaver JC, Powell KT, Mintzer RA, Sloan SR, Ling H. Bis-The Diffuse Permeability of Bilayer-Membranes the Contribution of Transient Aqueous Pores. Bioelectrochemistry and Bioenergetics. 1984; 12(3-4):405-412. View abstract
  92. Sandor T, Sloan S, D’Adamo AJ, Boxt LM, Harrington DP, Spears JR, Paulin S. Automation of Left Ventricular Contour Detection. Proceedings of the Society of Photo-Optical Instrumentation Engineers. 1984; 454:197-206. View abstract
  93. Sandor T, Sloan S, Dadamo AJ, Boxt LM, Harrington DP, Spears JR, Paulin S. Automation of Left-Ventricular Contour-Detection. Proceedings of the Society of Photo-Optical Instrumentation Engineers. 1984; 454:197-206. View abstract